The Management of Hypertension

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1986 Jan 1

PMID 3530297

Authors

B N Prichard

C W OWENS

Affiliations

Soon will be listed here.

References

Guazzi M, Olivari M, Polese A, Fiorentini C, Magrini F, Moruzzi P . Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther. 1977; 22(5 Pt 1):528-32. DOI: 10.1002/cpt1977225part1528. View

Olivari M, BARTORELLI C, Polese A, Fiorentini C, Moruzzi P, Guazzi M . Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation. 1979; 59(5):1056-62. DOI: 10.1161/01.cir.59.5.1056. View

Gould B, Hornung R, Mann S, Balasubramanian V, Raftery E . Slow channel inhibitors verapamil and nifedipine in the management of hypertension. J Cardiovasc Pharmacol. 1982; 4 Suppl 3:S369-73. View

Decalmer P, Chatterjee S, Cruickshank J, Benson M, STERLING G . Beta-blockers and asthma. Br Heart J. 1978; 40(2):184-9. PMC: 482795. DOI: 10.1136/hrt.40.2.184. View

Serlin M, Orme M, MacIver M, GREEN G, Macnee C, Breckenridge A . Rate of onset of hypotensive effect of oral labetalol. Br J Clin Pharmacol. 1979; 7(2):165-8. PMC: 1429443. DOI: 10.1111/j.1365-2125.1979.tb00916.x. View

Seideman P, Grahnen A, Haglund K, Lindstrom B, von Bahr C . Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients. Br J Clin Pharmacol. 1982; 13(6):865-70. PMC: 1402032. DOI: 10.1111/j.1365-2125.1982.tb01880.x. View

Simon G, Kiowski W, Julius S . Antihypertensive and beta-adrenoceptor antagonist action of timolol. Clin Pharmacol Ther. 1978; 23(2):152-7. DOI: 10.1002/cpt1978232152. View

Jurgensen J, Frederiksen J, Hansen D . Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol. Br Heart J. 1981; 45(5):583-8. PMC: 482568. DOI: 10.1136/hrt.45.5.583. View

Lehtonen A, Hietanen E, Marniemi J, Peltonen P, Niskanen J . Effect of pindolol on serum lipids and lipid metabolizing enzymes. Br J Clin Pharmacol. 1982; 13(Suppl 2):445S-447S. PMC: 1402150. DOI: 10.1111/j.1365-2125.1982.tb01955.x. View

10.

Prichard B . Beta-adrenergic receptor blocking drugs in angina pectoris. Drugs. 1974; 7(1):55-84. DOI: 10.2165/00003495-197407010-00005. View

11.

Smith C, McKendry R . Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet. 1982; 2(8311):1299-301. DOI: 10.1016/s0140-6736(82)91508-2. View

12.

Taylor C, Leader J, Singleton W, Munster E, Falkner F, ONeil J . Profile of trimazosin: an effective and safe antihypertensive agent. Am Heart J. 1983; 106(5 Pt 2):1269-81. DOI: 10.1016/0002-8703(83)90188-6. View

13.

Lithell H, Waern U, Vessby B . Effect of prazosin on lipoprotein metabolism in premenopausal, hypertensive women. J Cardiovasc Pharmacol. 1982; 4 Suppl 2:S242-4. View

14.

Hampton J . The use of beta blockers for the reduction of mortality after myocardial infarction. Eur Heart J. 1981; 2(4):259-68. DOI: 10.1093/oxfordjournals.eurheartj.a061206. View

15.

Velasco M, Silva H, Morillo J, Pellicer R . Effect of prazosin on blood lipids and on thyroid function in hypertensive patients. J Cardiovasc Pharmacol. 1982; 4 Suppl 2:S225-7. View

16.

Morgan T, Roberts R, Carney S, Louis W, Doyle A . Beta-adrenergic receptor blocking drugs, hypertension and plasma renin. Br J Clin Pharmacol. 1975; 2(2):159-64. PMC: 1402516. DOI: 10.1111/j.1365-2125.1975.tb01571.x. View

17.

TARAZI R, Bravo E, Fouad F, Omvik P, Cody Jr R . Hemodynamic and volume changes associated with captopril. Hypertension. 1980; 2(4):576-85. DOI: 10.1161/01.hyp.2.4.576. View

18.

Stokes G, Frost G, Graham R, MacCarthy E . Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension. Clin Pharmacol Ther. 1979; 25(6):783-9. DOI: 10.1002/cpt1979256783. View

19.

Peter T, Heng M, Singh B, Ambler P, Nisbet H, Elliot R . Failure of high doses of propranolol to reduce experimental myocardial ischemic damage. Circulation. 1978; 57(3):534-40. DOI: 10.1161/01.cir.57.3.534. View

20.

Dage R, Cheng H, WOODWARD J . Cardiovascular properties of medroxalol, a new antihypertensive drug. J Cardiovasc Pharmacol. 1981; 3(2):299-315. DOI: 10.1097/00005344-198103000-00009. View